
### [MONDO:0017957](http://purl.obolibrary.org/obo/MONDO_0017957)
**Label:** unclassified autoinflammatory syndrome

**Subclasses:** [MONDO:0014761](http://purl.obolibrary.org/obo/MONDO_0014761) (hereditary pediatric BehC'et-like disease), [MONDO:0007191](http://purl.obolibrary.org/obo/MONDO_0007191) (Behcet's syndrome), [MONDO:0016662](http://purl.obolibrary.org/obo/MONDO_0016662) (idiopathic recurrent pericarditis), [MONDO:0017958](http://purl.obolibrary.org/obo/MONDO_0017958) (MAGIC syndrome), 

**Mapped go classes:** [GO:0032495](http://purl.obolibrary.org/obo/GO_0032495) (response to muramyl dipeptide), [GO:1903364](http://purl.obolibrary.org/obo/GO_1903364) (positive regulation of cellular protein catabolic process), [GO:0032691](http://purl.obolibrary.org/obo/GO_0032691) (negative regulation of interleukin-1 beta production), [GO:0043621](http://purl.obolibrary.org/obo/GO_0043621) (protein self-association), [GO:0061578](http://purl.obolibrary.org/obo/GO_0061578) (Lys63-specific deubiquitinase activity), [GO:0002632](http://purl.obolibrary.org/obo/GO_0002632) (negative regulation of granuloma formation), [GO:0002677](http://purl.obolibrary.org/obo/GO_0002677) (negative regulation of chronic inflammatory response), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0002237](http://purl.obolibrary.org/obo/GO_0002237) (response to molecule of bacterial origin), [GO:0002634](http://purl.obolibrary.org/obo/GO_0002634) (regulation of germinal center formation), [GO:0002315](http://purl.obolibrary.org/obo/GO_0002315) (marginal zone B cell differentiation), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0002637](http://purl.obolibrary.org/obo/GO_0002637) (regulation of immunoglobulin production), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0034148](http://purl.obolibrary.org/obo/GO_0034148) (negative regulation of toll-like receptor 5 signaling pathway), [GO:0072666](http://purl.obolibrary.org/obo/GO_0072666) (establishment of protein localization to vacuole), [GO:0031397](http://purl.obolibrary.org/obo/GO_0031397) (negative regulation of protein ubiquitination), [GO:2000352](http://purl.obolibrary.org/obo/GO_2000352) (negative regulation of endothelial cell apoptotic process), [GO:0032720](http://purl.obolibrary.org/obo/GO_0032720) (negative regulation of tumor necrosis factor production), [GO:1902042](http://purl.obolibrary.org/obo/GO_1902042) (negative regulation of extrinsic apoptotic signaling pathway via death domain receptors), [GO:0034140](http://purl.obolibrary.org/obo/GO_0034140) (negative regulation of toll-like receptor 3 signaling pathway), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0035871](http://purl.obolibrary.org/obo/GO_0035871) (protein K11-linked deubiquitination), [GO:0032088](http://purl.obolibrary.org/obo/GO_0032088) (negative regulation of NF-kappaB transcription factor activity), [GO:0050728](http://purl.obolibrary.org/obo/GO_0050728) (negative regulation of inflammatory response), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0045732](http://purl.obolibrary.org/obo/GO_0045732) (positive regulation of protein catabolic process), [GO:0008234](http://purl.obolibrary.org/obo/GO_0008234) (cysteine-type peptidase activity), [GO:0008233](http://purl.obolibrary.org/obo/GO_0008233) (peptidase activity), [GO:0045736](http://purl.obolibrary.org/obo/GO_0045736) (negative regulation of cyclin-dependent protein serine/threonine kinase activity), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0032715](http://purl.obolibrary.org/obo/GO_0032715) (negative regulation of interleukin-6 production), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0010507](http://purl.obolibrary.org/obo/GO_0010507) (negative regulation of autophagy), [GO:0072573](http://purl.obolibrary.org/obo/GO_0072573) (tolerance induction to lipopolysaccharide), [GO:0050727](http://purl.obolibrary.org/obo/GO_0050727) (regulation of inflammatory response), [GO:0070433](http://purl.obolibrary.org/obo/GO_0070433) (negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway), [GO:0016567](http://purl.obolibrary.org/obo/GO_0016567) (protein ubiquitination), [GO:0070429](http://purl.obolibrary.org/obo/GO_0070429) (negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway), [GO:0009611](http://purl.obolibrary.org/obo/GO_0009611) (response to wounding), [GO:0060548](http://purl.obolibrary.org/obo/GO_0060548) (negative regulation of cell death), [GO:0002020](http://purl.obolibrary.org/obo/GO_0002020) (protease binding), [GO:0043124](http://purl.obolibrary.org/obo/GO_0043124) (negative regulation of I-kappaB kinase/NF-kappaB signaling), [GO:0045824](http://purl.obolibrary.org/obo/GO_0045824) (negative regulation of innate immune response), [GO:0032703](http://purl.obolibrary.org/obo/GO_0032703) (negative regulation of interleukin-2 production), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0043130](http://purl.obolibrary.org/obo/GO_0043130) (ubiquitin binding), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0001922](http://purl.obolibrary.org/obo/GO_0001922) (B-1 B cell homeostasis), [GO:0048662](http://purl.obolibrary.org/obo/GO_0048662) (negative regulation of smooth muscle cell proliferation), [GO:0070301](http://purl.obolibrary.org/obo/GO_0070301) (cellular response to hydrogen peroxide), [GO:0016874](http://purl.obolibrary.org/obo/GO_0016874) (ligase activity), [GO:0019900](http://purl.obolibrary.org/obo/GO_0019900) (kinase binding), [GO:0016579](http://purl.obolibrary.org/obo/GO_0016579) (protein deubiquitination), [GO:0071947](http://purl.obolibrary.org/obo/GO_0071947) (protein deubiquitination involved in ubiquitin-dependent protein catabolic process), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0070936](http://purl.obolibrary.org/obo/GO_0070936) (protein K48-linked ubiquitination), [GO:1904888](http://purl.obolibrary.org/obo/GO_1904888) (cranial skeletal system development), [GO:0004843](http://purl.obolibrary.org/obo/GO_0004843) (thiol-dependent ubiquitin-specific protease activity), [GO:0004842](http://purl.obolibrary.org/obo/GO_0004842) (ubiquitin-protein transferase activity), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:2000349](http://purl.obolibrary.org/obo/GO_2000349) (negative regulation of CD40 signaling pathway), [GO:0071222](http://purl.obolibrary.org/obo/GO_0071222) (cellular response to lipopolysaccharide), [GO:0070530](http://purl.obolibrary.org/obo/GO_0070530) (K63-linked polyubiquitin modification-dependent protein binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0045088](http://purl.obolibrary.org/obo/GO_0045088) (regulation of innate immune response), [GO:0006508](http://purl.obolibrary.org/obo/GO_0006508) (proteolysis), [GO:0050869](http://purl.obolibrary.org/obo/GO_0050869) (negative regulation of B cell activation), [GO:0034115](http://purl.obolibrary.org/obo/GO_0034115) (negative regulation of heterotypic cell-cell adhesion), [GO:2000347](http://purl.obolibrary.org/obo/GO_2000347) (positive regulation of hepatocyte proliferation), [GO:0070536](http://purl.obolibrary.org/obo/GO_0070536) (protein K63-linked deubiquitination), [GO:0071108](http://purl.obolibrary.org/obo/GO_0071108) (protein K48-linked deubiquitination), [GO:0036459](http://purl.obolibrary.org/obo/GO_0036459) (thiol-dependent ubiquitinyl hydrolase activity), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- [GO:0070425](http://purl.obolibrary.org/obo/GO_0070425) (negative regulation of nucleotide-binding oligomerization domain containing signaling pathway) 53.57%
- [GO:0070424](http://purl.obolibrary.org/obo/GO_0070424) (regulation of nucleotide-binding oligomerization domain containing signaling pathway) 53.57%
- [GO:0034122](http://purl.obolibrary.org/obo/GO_0034122) (negative regulation of toll-like receptor signaling pathway) 53.57%
- Thing 53.38%
- [GO:0072573](http://purl.obolibrary.org/obo/GO_0072573) (tolerance induction to lipopolysaccharide) 51.79%
- [GO:0070433](http://purl.obolibrary.org/obo/GO_0070433) (negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway) 51.79%
- [GO:0070432](http://purl.obolibrary.org/obo/GO_0070432) (regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway) 51.79%
- [GO:0070429](http://purl.obolibrary.org/obo/GO_0070429) (negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway) 51.79%
- [GO:0070428](http://purl.obolibrary.org/obo/GO_0070428) (regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway) 51.79%
- [GO:0034148](http://purl.obolibrary.org/obo/GO_0034148) (negative regulation of toll-like receptor 5 signaling pathway) 51.79%
- [GO:0034147](http://purl.obolibrary.org/obo/GO_0034147) (regulation of toll-like receptor 5 signaling pathway) 51.79%
- [GO:0034140](http://purl.obolibrary.org/obo/GO_0034140) (negative regulation of toll-like receptor 3 signaling pathway) 51.79%
- [GO:0002632](http://purl.obolibrary.org/obo/GO_0002632) (negative regulation of granuloma formation) 51.79%
- [GO:0002315](http://purl.obolibrary.org/obo/GO_0002315) (marginal zone B cell differentiation) 51.79%
- [GO:0001922](http://purl.obolibrary.org/obo/GO_0001922) (B-1 B cell homeostasis) 51.79%


